• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Glucokinase mutation-a rare cause of recurrent hypoglycemia in adults: a case report and literature review.葡萄糖激酶突变——成人复发性低血糖的罕见原因:一例报告及文献综述
J Community Hosp Intern Med Perspect. 2016 Oct 26;6(5):32983. doi: 10.3402/jchimp.v6.32983. eCollection 2016.
2
Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation.新发葡萄糖激酶突变导致的严重持续性高胰岛素血症性低血糖症
Diabetes. 2004 Aug;53(8):2164-8. doi: 10.2337/diabetes.53.8.2164.
3
Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.高血糖和低血糖中的葡萄糖激酶(GCK)突变:青少年发病的成年型糖尿病、永久性新生儿糖尿病和婴儿高胰岛素血症。
Hum Mutat. 2003 Nov;22(5):353-62. doi: 10.1002/humu.10277.
4
Non-insulinoma persistent hyperinsulinaemic hypoglycaemia caused by an activating glucokinase mutation: hypoglycaemia unawareness and attacks.由激活型葡萄糖激酶突变引起的非胰岛素瘤持续性高胰岛素血症性低血糖症:低血糖意识障碍与发作
Clin Endocrinol (Oxf). 2008 May;68(5):747-55. doi: 10.1111/j.1365-2265.2008.03184.x. Epub 2008 Jan 15.
5
Not Just an Accident: A Case of Insulinoma.绝非偶然:一例胰岛素瘤病例
Cureus. 2023 Nov 8;15(11):e48514. doi: 10.7759/cureus.48514. eCollection 2023 Nov.
6
Clinical and enzymatic phenotypes in congenital hyperinsulinemic hypoglycemia due to glucokinase-activating mutations: A report of two cases and a brief overview of the literature.葡萄糖激酶激活突变导致的先天性高胰岛素血症性低血糖的临床和酶学表型:两例报告及文献复习
J Diabetes Investig. 2019 Nov;10(6):1454-1462. doi: 10.1111/jdi.13072. Epub 2019 Jun 12.
7
Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report.孕期使用奥曲肽治疗家族性高胰岛素性低血糖症后的不良妊娠结局:一例报告
BMC Res Notes. 2014 Nov 17;7:804. doi: 10.1186/1756-0500-7-804.
8
Diagnosis, treatment and genetic analysis of a case of hypoglycemia caused by glucokinase gene mutation.诊断、治疗一例因葡萄糖激酶基因突变引起的低血糖症及基因分析。
Yi Chuan. 2022 Sep 20;44(9):810-818. doi: 10.16288/j.yczz.22-128.
9
Heterogeneity in phenotype of hyperinsulinism caused by activating glucokinase mutations: a novel mutation and its functional characterization.由激活型葡萄糖激酶突变引起的高胰岛素血症表型异质性:一种新突变及其功能特征
Clin Endocrinol (Oxf). 2017 Jun;86(6):778-783. doi: 10.1111/cen.13318. Epub 2017 Mar 27.
10
Diagnostic difficulties in glucokinase hyperinsulinism.葡萄糖激酶高胰岛素血症的诊断困难
Horm Metab Res. 2009 Apr;41(4):320-6. doi: 10.1055/s-0028-1102922. Epub 2008 Dec 3.

引用本文的文献

1
Clinical Profile and Efficacy of Long-Acting Octreotide in Hyperinsulinemic Hypoglycaemia.长效奥曲肽治疗高胰岛素性低血糖症的临床特征与疗效
Indian J Endocrinol Metab. 2024 May-Jun;28(3):289-294. doi: 10.4103/ijem.ijem_483_23. Epub 2024 Jun 26.
2
Genotype-histotype-phenotype correlations in hyperinsulinemic hypoglycemia.胰岛素血症性低血糖的基因型-表型相关性。
Histol Histopathol. 2024 Jul;39(7):817-844. doi: 10.14670/HH-18-709. Epub 2024 Jan 12.
3
Genetic variants of ABCC8 and clinical manifestations in eight Chinese children with hyperinsulinemic hypoglycemia.ABCC8 基因变异与 8 例中国高胰岛素血症低血糖患儿临床表现的关系
BMC Endocr Disord. 2024 Jan 12;24(1):8. doi: 10.1186/s12902-023-01527-8.
4
Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations.新型葡萄糖激酶激活突变致先天性高胰岛素血症的表型特征。
Diabetes. 2023 Dec 1;72(12):1809-1819. doi: 10.2337/db23-0465.
5
TWO OPPOSITE PHENOTYPES OF GLUCOSE DISORDERS IN A FAMILY WITH HETEROZYGOUS P.SER453LEU (C.1358C> T) MUTATION IN THE GLUCOKINASE (GCK) GENE: MATURITY ONSET DIABETES IN YOUNG AND INSULINOMA.葡萄糖激酶(GCK)基因中存在杂合性P.Ser453Leu(C.1358C>T)突变的一个家族中的两种相反的葡萄糖代谢紊乱表型:青年发病的成年型糖尿病和胰岛素瘤。
Acta Endocrinol (Buchar). 2022 Oct-Dec;18(4):458-465. doi: 10.4183/aeb.2022.458.
6
Hyperinsulinaemic hypoglycaemia-an overview of a complex clinical condition.高胰岛素血症性低血糖概述:一种复杂的临床病症。
Eur J Pediatr. 2019 Aug;178(8):1151-1160. doi: 10.1007/s00431-019-03414-8. Epub 2019 Jun 26.
7
Clinical and enzymatic phenotypes in congenital hyperinsulinemic hypoglycemia due to glucokinase-activating mutations: A report of two cases and a brief overview of the literature.葡萄糖激酶激活突变导致的先天性高胰岛素血症性低血糖的临床和酶学表型:两例报告及文献复习
J Diabetes Investig. 2019 Nov;10(6):1454-1462. doi: 10.1111/jdi.13072. Epub 2019 Jun 12.
8
The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism.先天性高胰岛素血症的遗传和分子机制
Front Endocrinol (Lausanne). 2019 Feb 26;10:111. doi: 10.3389/fendo.2019.00111. eCollection 2019.
9
Congenital Hyperinsulinism: Diagnosis and Treatment Update.先天性高胰岛素血症:诊断与治疗的最新进展
J Clin Res Pediatr Endocrinol. 2017 Dec 30;9(Suppl 2):69-87. doi: 10.4274/jcrpe.2017.S007. Epub 2017 Dec 27.
10
Diagnosis and treatment of hyperinsulinaemic hypoglycaemia and its implications for paediatric endocrinology.高胰岛素血症性低血糖症的诊断与治疗及其对儿科内分泌学的影响
Int J Pediatr Endocrinol. 2017;2017:9. doi: 10.1186/s13633-017-0048-8. Epub 2017 Aug 29.

本文引用的文献

1
Congenital hyperinsulinism: current status and future perspectives.先天性高胰岛素血症:现状与未来展望
Ann Pediatr Endocrinol Metab. 2014 Jun;19(2):57-68. doi: 10.6065/apem.2014.19.2.57. Epub 2014 Jun 30.
2
Role of (18) F-FDOPA PET/CT imaging in endocrinology.(18)F - 多巴PET/CT成像在内分泌学中的作用。
Clin Endocrinol (Oxf). 2014 Dec;81(6):789-98. doi: 10.1111/cen.12566. Epub 2014 Sep 1.
3
A patent review of glucokinase activators and disruptors of the glucokinase--glucokinase regulatory protein interaction: 2011-2014.2011-2014 年葡萄糖激酶激活剂和葡萄糖激酶-葡萄糖激酶调节蛋白相互作用调节剂的专利研究综述。
Expert Opin Ther Pat. 2014 Aug;24(8):875-91. doi: 10.1517/13543776.2014.918957. Epub 2014 May 12.
4
Insulin-like growth factor 1 predicts post-load hypoglycemia following bariatric surgery: a prospective cohort study.胰岛素样生长因子1预测减重手术后负荷后低血糖:一项前瞻性队列研究。
PLoS One. 2014 Apr 15;9(4):e94613. doi: 10.1371/journal.pone.0094613. eCollection 2014.
5
Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.葡萄糖激酶调节蛋白小分子抑制剂的抗糖尿病作用。
Nature. 2013 Dec 19;504(7480):437-40. doi: 10.1038/nature12724. Epub 2013 Nov 13.
6
Evolution of glucose utilization: glucokinase and glucokinase regulator protein.葡萄糖利用的演变:葡萄糖激酶和葡萄糖激酶调节蛋白。
Mol Phylogenet Evol. 2014 Jan;70:195-203. doi: 10.1016/j.ympev.2013.09.016. Epub 2013 Sep 25.
7
Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism.皮下注射胰高血糖素成功用于治疗先天性高胰岛素血症所致的持续性低血糖症。
J Pediatr Endocrinol Metab. 2013;26(11-12):1157-61. doi: 10.1515/jpem-2013-0115.
8
New insights and new conundrums in neonatal hypoglycemia: enigmas wrapped in mystery.新生儿低血糖症的新见解与新难题:谜团之中的谜题。
Diabetes. 2013 May;62(5):1373-5. doi: 10.2337/db12-1839.
9
Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management.单基因高胰岛素血症性低血糖症:发病机制与管理的最新见解
Int J Pediatr Endocrinol. 2013 Feb 6;2013(1):3. doi: 10.1186/1687-9856-2013-3.
10
Hypoglycaemia related to inherited metabolic diseases in adults.成人遗传性代谢疾病相关低血糖症。
Orphanet J Rare Dis. 2012 May 15;7:26. doi: 10.1186/1750-1172-7-26.

葡萄糖激酶突变——成人复发性低血糖的罕见原因:一例报告及文献综述

Glucokinase mutation-a rare cause of recurrent hypoglycemia in adults: a case report and literature review.

作者信息

Ajala Oluremi N, Huffman David M, Ghobrial Ibrahim I

机构信息

Department of Internal Medicine, University of Pittsburgh Medical Center, McKeesport, PA, USA;

Department of Internal Medicine, University of Tennessee College of Medicine, Chattanooga, TN, USA.

出版信息

J Community Hosp Intern Med Perspect. 2016 Oct 26;6(5):32983. doi: 10.3402/jchimp.v6.32983. eCollection 2016.

DOI:10.3402/jchimp.v6.32983
PMID:27802864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5089152/
Abstract

BACKGROUND

Hypoglycemia occurs frequently in patients both in the inpatient and outpatient settings. While most hypoglycemia unrelated to diabetes treatment results from excessive endogenous insulin action, rare cases involve functional and congenital mutations in glycolytic enzymes of insulin regulation.

CASE

A 21-year-old obese woman presented to the emergency department with complaints of repeated episodes of lethargy, syncope, dizziness, and sweating. She was referred from an outside facility on suspicion of insulinoma, with severe hypoglycemia unresponsive to repeated dextrose infusions. Her plasma glucose was 20 mg/dl at presentation, 44 mg/dl on arrival at our facility, and remained low in spite of multiple dextrose infusions. The patient had been treated for persistent hyperinsulinemic hypoglycemia of infancy at our neonatal facility and 4 years ago was diagnosed as having an activating glucokinase (GCK) mutation. She was then treated with octreotide and diazoxide with improvement in symptoms and blood glucose levels.

CONCLUSION

Improved diagnostication and management of uncommon genetic mutations as typified in this patient with an activating mutation of the GCK gene has expanded the spectrum of disease in adult medicine. This calls for improved patient information dissemination across different levels and aspects of the health care delivery system to ensure cost-effective and timely health care.

摘要

背景

低血糖在住院患者和门诊患者中均频繁发生。虽然大多数与糖尿病治疗无关的低血糖是由内源性胰岛素作用过度引起的,但罕见病例涉及胰岛素调节糖酵解酶的功能性和先天性突变。

病例

一名21岁肥胖女性因反复出现嗜睡、晕厥、头晕和出汗症状就诊于急诊科。她从外部机构转诊而来,怀疑患有胰岛素瘤,严重低血糖对反复输注葡萄糖无反应。就诊时她的血浆葡萄糖为20mg/dl,到达我院时为44mg/dl,尽管多次输注葡萄糖仍维持在低水平。该患者曾在我院新生儿科接受过婴儿持续性高胰岛素血症性低血糖的治疗,4年前被诊断为具有激活型葡萄糖激酶(GCK)突变。随后她接受了奥曲肽和二氮嗪治疗,症状和血糖水平有所改善。

结论

对于像该GCK基因激活突变患者这样典型的罕见基因突变,其诊断和管理的改善拓宽了成人医学的疾病谱。这就要求在医疗服务体系的不同层面和方面加强患者信息传播,以确保提供具有成本效益且及时的医疗服务。